Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder

Autor: Katila, Heikki, Mezhebovsky, Irina, Mulroy, Amy, Berggren, Lovisa, Eriksson, Hans, Earley, Willie, Datto, Catherine

Publikováno v: In The American Journal of Geriatric Psychiatry August 2013 21(8):769-784

Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study

Autor: Khan, Arifulla, Atkinson, Sarah, Mezhebovsky, Irina, She, Fahua, Leathers, Todd, Pathak, Sanjeev

To evaluate the efficacy and tolerability of adjunct extended release quetiapine fumarate (quetiapine XR) in patients with generalized anxiety disorder (GAD) and inadequate response to selective serotonin reuptake inhibitors/ serotonin norepinephrine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9bf920c04b02768a0b1d3deff303a047
https://europepmc.org/articles/PMC5044479/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study.

Autor: Khan A; Dr. Khan, MD, Northwest Clinical Research Center, Bellevue, WA; Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC. Dr. Atkinson, MD, Finger Lakes Clinical Research, Rochester, NY. Dr. Mezhebovsky, MD, Boston Clinical Trials Inc, Boston, MA. Drs. She, MD and Pathak, MD and Mr Leathers, MBA, AstraZeneca Pharmaceuticals, Wilmington, DE, USA., Atkinson S; Dr. Khan, MD, Northwest Clinical Research Center, Bellevue, WA; Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC. Dr. Atkinson, MD, Finger Lakes Clinical Research, Rochester, NY. Dr. Mezhebovsky, MD, Boston Clinical Trials Inc, Boston, MA. Drs. She, MD and Pathak, MD and Mr Leathers, MBA, AstraZeneca Pharmaceuticals, Wilmington, DE, USA., Mezhebovsky I; Dr. Khan, MD, Northwest Clinical Research Center, Bellevue, WA; Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC. Dr. Atkinson, MD, Finger Lakes Clinical Research, Rochester, NY. Dr. Mezhebovsky, MD, Boston Clinical Trials Inc, Boston, MA. Drs. She, MD and Pathak, MD and Mr Leathers, MBA, AstraZeneca Pharmaceuticals, Wilmington, DE, USA., She F; Dr. Khan, MD, Northwest Clinical Research Center, Bellevue, WA; Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC. Dr. Atkinson, MD, Finger Lakes Clinical Research, Rochester, NY. Dr. Mezhebovsky, MD, Boston Clinical Trials Inc, Boston, MA. Drs. She, MD and Pathak, MD and Mr Leathers, MBA, AstraZeneca Pharmaceuticals, Wilmington, DE, USA., Leathers T; Dr. Khan, MD, Northwest Clinical Research Center, Bellevue, WA; Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC. Dr. Atkinson, MD, Finger Lakes Clinical Research, Rochester, NY. Dr. Mezhebovsky, MD, Boston Clinical Trials Inc, Boston, MA. Drs. She, MD and Pathak, MD and Mr Leathers, MBA, AstraZeneca Pharmaceuticals, Wilmington, DE, USA., Pathak S; Dr. Khan, MD, Northwest Clinical Research Center, Bellevue, WA; Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC. Dr. Atkinson, MD, Finger Lakes Clinical Research, Rochester, NY. Dr. Mezhebovsky, MD, Boston Clinical Trials Inc, Boston, MA. Drs. She, MD and Pathak, MD and Mr Leathers, MBA, AstraZeneca Pharmaceuticals, Wilmington, DE, USA.

Publikováno v: Psychopharmacology bulletin [Psychopharmacol Bull] 2011 May 15; Vol. 44 (2), pp. 5-31.